Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05563077 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Aerobic Exercise and Resistant Hypertension

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 18, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv7
  2. Primary completion date: Aug 2025 to Nov 1, 2025
    • Study completion date: Aug 2025 to Nov 15, 2025
    • Secondary endpoints: details revised at 1 of 3 entries
    v6
  3. Eligibility criteria revisedv5
  4. Primary completion date: Aug 2024 to Aug 2025v4 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Secondary endpoints: 1 to 3
    • Study description shortened, about 18 words
    • Site details revised
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2022 to Oct 5, 2022
    • Site details revised
    v3
  6. Start date: Sep 2022 to Oct 2022v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine the effects of 4 months of aerobic interval training versus continuous aerobic training on ambulatory blood pressure (ABP) and novel plasma protein biomarkers in patients with resistant hypertension. A randomized controlled trial will be performed including two exercise groups and a control group: a) moderate-intensity interval training (MIIT); b) moderate-intensity continuous training (MICT); c) usual care. MIIT could represent a superior training modality that exceeds the benefits of MICT in patients with resistant hypertension.
Trial Details
NCT Number NCT05563077
Lead Sponsor Universidad Europea de Madrid
Conditions
(from sponsor)		 Resistant Hypertension
Related terms Motor Activity
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov